细胞裂解市场规模、份额及成长分析（依产品类型、细胞类型、应用、最终用户及地区划分）－2026-2033年产业预测

预计到 2024 年，细胞裂解市场规模将达到 35.7 亿美元，到 2025 年将达到 38.3 亿美元，到 2033 年将达到 66.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 7.2%。

细胞裂解市场正经历强劲成长，这主要得益于基因组学、蛋白质组学和细胞分析等多个研究领域对细胞裂解技术日益增长的需求。细胞裂解是提取重要的细胞内成分和生物分子（例如DNA、RNA、蛋白质和细胞器）的关键步骤，在分析和实验应用中发挥至关重要的作用。药物研发活动的激增、个人化医疗的兴起以及生物技术的进步，都显着推动了对高效、高品质细胞裂解方法的需求。此外，慢性病发生率的上升以及对精准诊断工具需求的增加，也进一步促进了市场扩张。细胞裂解技术的创新和自动化，将为市场未来的持续成长奠定基础。

细胞裂解市场驱动因素

推动全球细胞裂解市场发展的关键因素是製药、生物技术和诊断等多个领域对基于细胞的研究和开发需求的激增。细胞裂解在分离细胞成分以进行后续分析和实验方面发挥着至关重要的作用。随着个人化医疗、药物发现和基因组学研究的日益普及，细胞裂解的重要性与日俱增。此外，细胞裂解技术的不断进步，包括以微珠为基础的技术和高通量系统，透过提高研究方法的效率、扩充性和可重复性，正在推动市场扩张。这些趋势共同为细胞裂解解决方案创造了蓬勃发展的环境。

限制细胞裂解市场的激素

全球细胞裂解市场面临一项重大挑战：相关产品和设备的高成本。各种技术都需要使用专用试剂、耗材和设备，这些成本可能非常高。对于预算有限的研究人员和实验室，尤其是在发展中地区，这种经济负担可能构成重大障碍。此外，准确执行细胞裂解操作需要熟练的专业人员，这进一步增加了成本。这些因素可能会限制细胞裂解技术的应用，尤其是在资源匮乏的环境中，阻碍市场成长。

细胞裂解市场趋势

细胞裂解市场正呈现自动化和高通量系统应用显着成长的趋势。随着细胞生物学的日益复杂，研究人员越来越需要高效可靠的方法来破坏细胞膜并提取细胞内成分。自动化系统具有许多优势，例如精确控制、可重复性和扩充性，从而简化了细胞裂解流程。这种自动化不仅减少了人工操作，还增强了基因组学、蛋白质组学、药物研发和诊断研究等多个应用领域的工作流程整合。随着实验室不断追求更高的生产效率和一致、标准化的结果，对这些先进解决方案的需求预计将稳定成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球细胞裂解市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 消耗品
  • 试剂盒和试剂
  • 酵素
  • 清洁剂溶液
  • 其他的
  • 一次性产品
  • 其他的
• 装置
  • 超音波处理设备
  • 均质机
  • 法式滤压壶
  • 微射流发生器
  • 珠磨机
  • 其他设备

全球细胞裂解市场规模（依细胞类型划分）及复合年增长率（2026-2033 年）

• 哺乳动物细胞
• 微生物细胞
• 细菌细胞
• 其他细胞

全球细胞裂解市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 蛋白质纯化与分离
• 细胞器分离
• 核酸分离与纯化
• 其他应用

全球细胞裂解市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 研究所
• 生物製药和生物技术
• 其他最终用户

全球细胞裂解市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc.（USA）
• Danaher Corporation（USA）
• Qiagen NV（Netherlands）
• Merck KGaA（Germany）
• Bio-Rad Laboratories, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Covaris, Inc.（USA）
• Parr Instrument Company（USA）
• Claremont BioSolutions, LLC（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Miltenyi Biotec（Germany）
• Sartorius AG（Germany）
• Beckman Coulter, Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Promega Corporation（USA）
• Takara Bio Inc.（Japan）
• Cell Signaling Technology, Inc.（USA）
• Qsonica（USA）
• Lonza（Switzerland）
• STEMCELL Technologies Inc.（Canada）

结论与建议

Cell Lysis Market size was valued at USD 3.57 Billion in 2024 and is poised to grow from USD 3.83 Billion in 2025 to USD 6.67 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The cell lysis market is experiencing robust growth, fueled by the escalating demand for cell lysis techniques across diverse research fields, including genomics, proteomics, and cell-based assays. Essential for extracting key intracellular components and biomolecules-such as DNA, RNA, proteins, and organelles-cell lysis plays a vital role in analysis and experimentation. The surge in drug discovery efforts, the move towards personalized medicine, and advancements in biotechnology significantly boost demand for efficient, high-quality cell lysis methods. Additionally, the rising incidence of chronic diseases and the growing need for precise diagnostic tools further propel the market's expansion. Innovations and automation in cell lysis technologies position the market favorably for sustained growth in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Lysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Lysis Market Segments Analysis

Global Cell Lysis Market is segmented by product, cell type, application, end user, research laboratories and institutes, biopharmaceutical and biotechnology companies, other end user and region. Based on product, the market is segmented into consumables and instruments. Based on cell type, the market is segmented into mammalian cells, microbial cells, bacterial cells and other cells. Based on application, the market is segmented into protein purification and isolation, cell organelle isolation, nucleic acid isolation and purification and other application. Based on end user, the market is segmented into Research Laboratories and Institutes, biopharmaceutical and biotechnology companies, other end user. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Lysis Market

A significant factor propelling the global cell lysis market is the surging demand for cell-based research and development across diverse sectors such as pharmaceuticals, biotechnology, and diagnostics. Cell lysis plays a crucial role in isolating cellular components for in-depth analysis and experimentation, which is becoming increasingly vital due to the heightened emphasis on personalized medicine, drug discovery, and genomics research. Furthermore, ongoing advancements in cell lysis technologies, including bead-based techniques and high-throughput systems, are enhancing market expansion by providing improved efficiency, scalability, and reproducibility in research processes. These trends collectively contribute to a thriving environment for cell lysis solutions.

Restraints in the Cell Lysis Market

The global cell lysis market faces a significant challenge due to the high expenses linked to cell lysis products and equipment. The various techniques involved often necessitate the use of specialized reagents, consumables, and instruments, which can be prohibitively costly. This financial burden can be particularly daunting for researchers and laboratories operating on limited budgets, especially in less developed regions. Additionally, the requirement for skilled personnel to execute cell lysis procedures accurately further escalates costs. Such factors can restrict the adoption of cell lysis technologies and consequently impede market growth, especially in resource-limited environments.

Market Trends of the Cell Lysis Market

The cell lysis market is experiencing a notable trend toward the adoption of automated and high-throughput systems. Researchers increasingly require efficient and reliable methods for disrupting cell membranes to extract intracellular components, driven by the complexities of cellular biology. Automated systems present significant advantages, including precise control, reproducibility, and scalability, which streamline cell lysis processes. This automation not only reduces manual labor but also enhances workflow integration across diverse applications such as genomics, proteomics, drug discovery, and diagnostic research. As laboratories aim for improved productivity and consistent, standardized outcomes, the demand for these advanced solutions is anticipated to rise steadily.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Lysis Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Kits And Reagents
  • Enzymes
  • Detergent Solutions
  • Others
  • Disposables
  • Others
• Instruments
  • Sonicators
  • Homogenizers
  • French Press
  • Microfluidizer
  • Bead Mill
  • Other Instruments

Global Cell Lysis Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• Mammalian Cells
• Microbial Cells
• Bacterial Cells
• Other Cells

Global Cell Lysis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Protein Purification And Isolation
• Cell Organelle Isolation
• Nucleic Acid Isolation And Purification
• Other Application

Global Cell Lysis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Research Laboratories And Institutes
• Biopharmaceutical And Biotechnology
• Other End User

Global Cell Lysis Market Size & CAGR (2026-2033)

• North America (Product, Cell Type, Application, End User)
  • US
  • Canada
• Europe (Product, Cell Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Cell Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Cell Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Cell Type, Application, End User,)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covaris, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parr Instrument Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Claremont BioSolutions, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qsonica (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations